Aurobindo pharma: Game-Changing Deal Massive Profits Expected,Target ₹1200 by Year End| Anil Singhvi
Zee Business Video Team | Updated: September 29, 2023 11:15 am
Big news for Aurobindo Pharma Approval for the launch of Aurobindo Pharma's drug Revlimid Revlimid's market size is ₹35 thousand crores Aurobindo Pharma estimates sales of ₹4000-5000 crore Why did Anil Singhvi say - 'Share price ready to reach ₹ 1200 within a year'
